Ion mobility and liquid chromatography/mass spectrometry strategies for exhaled breath condensate glucose quantitation in cystic fibrosis studies
- 9 September 2013
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 27 (20) , 2263-2271
Abstract
RATIONALE: Cystic fibrosis related diabetes (CFRD) is an important complication of cystic fibrosis (CF) because it causes acceleration in the decline in lung function. Monitoring concentrations of key metabolites such as glucose in airway lining fluid is necessary for improving our understanding of the biochemical mechanisms linking diabetes and CF. Targeted‐metabolomic strategies for glucose quantitation in exhaled breath condensate (EBC) from healthy individuals are presented. METHODS: Three different electrospray ionization mass spectrometry (ESI‐MS)‐based methods were developed for EBC sample interrogation and glucose quantitation without derivatization. Two methods utilized ultra‐high‐performance liquid chromatography (UHPLC) coupled to either time‐of‐flight (TOF) MS or triple quadrupole (QqQ) tandem MS (MS/MS). A third approach involved direct‐infusion traveling wave ion mobility spectrometry (TWIMS) with TOF‐MS detection. UHPLC/QqQ‐MS/MS was used for urea quantitation as the EBC dilution marker. Matrix effects were mitigated using isotopically labeled glucose and urea as internal standards. RESULTS: All the developed methods allowed glucose and urea quantitation in EBC with high accuracy and precision. The UHPLC/TOF‐MS and UHPLC/QqQ‐MS/MS methods provided similar analytical figures of merit. UHPLC/QqQ‐MS/MS provided the highest sensitivity and the lowest limit of detection (LOD) of 1.5 nM in EBC for both glucose and urea. The TWIMS‐TOF‐MS‐based method provided the highest sample throughput capability; however, the glucose LOD was ~3‐fold higher than with the two chromatographic methods. CONCLUSIONS: Mass spectrometric methods for the quantitative analysis of trace EBC glucose levels are reported and compared for the first time. The analytical figures of merit demonstrate the applicability of these methods to metabolite analysis of airway samples for CF and CFRD research. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 45 references indexed in Scilit:
- Derivatization of carbohydrates for analysis by chromatography; electrophoresis and mass spectrometryJournal of Chromatography B, 2011
- Clinical Care Guidelines for Cystic Fibrosis–Related DiabetesDiabetes Care, 2010
- Metabolic profiling of human blood by high-resolution ion mobility mass spectrometry (IM-MS)International Journal of Mass Spectrometry, 2010
- Cystic fibrosis: Exploiting its genetic basis in the hunt for new therapiesPharmacology & Therapeutics, 2010
- Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and MortalityDiabetes Care, 2009
- Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensateRapid Communications in Mass Spectrometry, 2008
- Using a nanoelectrospray-differential mobility spectrometer-mass spectrometer system for the analysis of oligosaccharides with solvent selected control over ESI aggregate ion formationJournal of the American Society for Mass Spectrometry, 2007
- Analysis of tear glucose concentration with electrospray ionization mass spectrometryJournal of the American Society for Mass Spectrometry, 2007
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006